(and dosage form):
Each 5 mL contains Dextromethorphan hydrobromide 15 mg and Phenylpropanolamine hydrochloride 12,5 mg
Preserved with methyl hydroxybenzoate 3,125 mg and propyl hydroxybenzoate 0,625 mg per 5 mL
Contains ethyl alcohol 8 % v/v
A 10.1 (Antitussives and expectorants)
Ornacolis specifically formulated for temporary relief from coughing and nasal congestion associated with the common cold and sinusitis.
Ornacolcontains no sedatives or antihistamines and therefore does not produce drowsiness in most patients. This makes it particularly suited for working patients and others who must remain alert.
Ornacolcontains dextromethorphan hydrobromide, a synthetic, non-narcotic cough suppressant with efficacy equal to that of codeine but with particularly low incidence of adverse reactions.
Ornacolcontains phenylpropanolamine hydrochloride, which provides vasoconstriction similar to that of ephedrine but with less CNS stimulation.
Temporary relief from coughing and nasal congestion associated with the common cold, sinusitis, and upper respiratory tract infections.
As with any product containing a sympathomimetic Ornacolshould not be used in patients lacking MAO inhibitors or within about ten days of discontinuation of such treatment.
Use with caution in persons with hypertension, heart disease, thyroid disease or diabetes.
DOSAGE AND DIRECTIONS FOR USE:
Adults and Children over 12 years:
10 mL (two medicine measurefuls) 4 times a day.
Children 4 - 12 years:
5 mL (one medicine measureful) 4 times a day.
Children 2 - 4 years:
2,5 mL (one half medicine measureful) 4 times a day.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Adverse reactions are mild and infrequent as with the individual ingredients, and may include drowsiness, headache, insomnia, nausea, rash and vertigo
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
No cases of overdosage with Ornacolhave been reported, but it is likely that symptoms would be those of the individual components.
Symptoms: May include rapid pulse and respiration, disorientation, elevated blood pressure, tachycardia, dilated pupils, headache, excitation of the CNS, nausea and vomiting, gastro-intestinal upset, and anorexia.
Treatment: Treatment is essentially symptomatic. Immediate evacuation of the stomach should be induced through emesis and gastric lavage. If marked excitement is present, one of the short-acting barbiturates or chloral hydrate may be used.
CONDITIONS OF REGISTRATION:
A clear red viscous liquid with a cherry/strawberry flavour and chloroform overtones.
Supplied in 100 mL glass bottles.
Store at room temperature below 25°C.
Keep out of reach of children.
Reg. No. G/10.1/81
Smith Kline & French (Pty) Limited
Reg. No. 05/02856/07
Isando Road, Isando, Transvaal
DATE OF PUBLICATION:
||Code 0196 Spec 0988|
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998